What was the mood like at a big gene therapy conference last week? Why is Novo Nordisk's CEO stepping down? And why has Adam been in such a good mood?
We discuss all that and more on this week's episode of "The Readout LOUD," STAT's biotech podcast. We chat about M&A deals picking up, leadership changes at Novo, and recent FDA advisory committee meetings for cancer drugs. We also bring on STAT reporter Jason Mast to talk about the latest research and sentiment at the annual American Society of Cell and Gene Therapy meeting.
Listen Now
For more on the promising results of a personalized gene therapy presented at ASCGT, go here; for more on scientists' reluctance to discuss new FDA regulator Vinay Prasad at the meeting, go here; to read more on the business overhaul at the gene editing company Prime Medicines, go here; and to learn more the changes at Novo, go here.
Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode
Visit the archive to see past episodes
No comments